Hangzhou Alltest Biotech Co. Ltd. A (688606) — Cash Flow Quality Index
Hangzhou Alltest Biotech Co. Ltd. A (688606) has a Cash Flow Quality Index of 0.96x as of September 2025. Operating cash flow of CN¥55.21 Million is below net income of CN¥57.80 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Hangzhou Alltest Biotech Co. Ltd. A cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Hangzhou Alltest Biotech Co. Ltd. A Cash Flow Quality Index (2016–2025)
Historical Cash Flow Quality Index for Hangzhou Alltest Biotech Co. Ltd. A across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Hangzhou Alltest Biotech Co. Ltd. A cash flow conversion.
Annual Cash Flow Quality Index for Hangzhou Alltest Biotech Co. Ltd. A (2016–2025)
Year-by-year earnings quality comparison for Hangzhou Alltest Biotech Co. Ltd. A.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.94x | CN¥206.59 Million | CN¥220.19 Million | ▼ -13.8% |
| 2024 | 1.09x | CN¥329.52 Million | CN¥302.91 Million | ▲ +692.0% |
| 2023 | 0.14x | CN¥24.76 Million | CN¥180.28 Million | ▼ -88.0% |
| 2022 | 1.15x | CN¥1.36 Billion | CN¥1.19 Billion | ▼ -4.8% |
| 2021 | 1.21x | CN¥923.87 Million | CN¥765.69 Million | ▲ +31.6% |
| 2020 | 0.92x | CN¥622.72 Million | CN¥679.23 Million | ▼ -21.5% |
| 2019 | 1.17x | CN¥91.53 Million | CN¥78.42 Million | ▲ +254.1% |
| 2018 | 0.33x | CN¥18.60 Million | CN¥56.43 Million | ▼ -43.5% |
| 2017 | 0.58x | CN¥19.99 Million | CN¥34.24 Million | ▲ +33.3% |
| 2016 | 0.44x | CN¥6.72 Million | CN¥15.33 Million | — |